The global Chronic Kidney Disease (CKD) drugs market is witnessing steady growth, driven by the increasing prevalence of kidney-related disorders and continuous advancements in pharmaceutical research. Valued at US$ 14.8 billion in 2023, the market is projected to expand at a CAGR of 4.2% from 2024 to 2034, reaching US$ 23.8 billion by the end of 2034. As healthcare systems worldwide focus more...